Nitrofurantoin Monohydrate Macrocrystalline | Nitrofurantoin Monohydrate Capsule Breastfeeding
Breast milk is superior in nutrition, It provides resistance against infections and allergies, It is naturally sterile. Despite all the advantages of breastfeeding some mothers choose to pause the breastfeeding in fear of harmful effects of medicines passing in breast milk. Are you wondering about breastfeeding and using Nitrofurantoin Monohydrate Macrocrystalline | Nitrofurantoin Monohydrate Capsule ? Know what is Nitrofurantoin Monohydrate Macrocrystalline | Nitrofurantoin Monohydrate Capsule and how it can affect your breast milk and whether Nitrofurantoin Monohydrate Macrocrystalline | Nitrofurantoin Monohydrate Capsule is safe for your kid or not.

What is Nitrofurantoin Monohydrate Macrocrystalline | Nitrofurantoin Monohydrate Capsule ?


Nitrofurantoin monohydrate/macrocrystals capsules are indicated only for the treatment of acute uncomplicated urinary tract infections (acute cystitis) caused by susceptible strains of Escherichia colior Staphylococcus saprophyticus. Nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses. To reduce the development of drug-resistant bacteria and maintain the effectiveness of nitrofurantoin monohydrate/macrocrystals capsules and other antibacterial drugs, nitrofurantoin monohydrate/macrocrystals capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Nitrofurantoins lack the broader tissue distribution of other therapeutic agents approved for urinary tract infections. Consequently, many patients who are treated with nitrofurantoin monohydrate/macrocrystals capsules are predisposed to persistence or reappearance of bacteriuria. (See CLINICAL STUDIES.) Urine specimens for culture and susceptibility testing should be obtained before and after completion of therapy. If persistence or reappearance of bacteriuria occurs after treatment with nitrofurantoin monohydrate/macrocrystals capsules, other therapeutic agents with broader tissue distribution should be selected. In considering the use of nitrofurantoin monohydrate/macrocrystals capsules, lower eradication rates should be balanced against the increased potential for systemic toxicity and for the development of antimicrobial resistance when agents with broader tissue distribution are utilized.

Can I use Nitrofurantoin Monohydrate Macrocrystalline | Nitrofurantoin Monohydrate Capsule while breastfeeding?

Nitrofurantoin Monohydrate Macrocrystalline | Nitrofurantoin Monohydrate Capsule safe for breastfeeding
There are 2 main ingredients of Nitrofurantoin Monohydrate Macrocrystalline | Nitrofurantoin Monohydrate Capsule, Nitrofurantoin and Nitrofurantoin. One by one we have analyzed both Nitrofurantoin and Nitrofurantoin for its impact on breastfeeding and based on our analysis we can conclude that Nitrofurantoin Monohydrate Macrocrystalline | Nitrofurantoin Monohydrate Capsule is safe to use in breastfeeding. We recommend you to check our analysis of Nitrofurantoin and Nitrofurantoin as below.

Nitrofurantoin Monohydrate Macrocrystalline | Nitrofurantoin Monohydrate Capsule Breastfeeding Analsys


Nitrofurantoin while Breastfeeding

Safe

CAS Number: 67-20-9

Excretion into breast milk is clinically non-significant with no side-effects observed among breastfed infants from treated mothers except rare cases of diarrhea. Do not use while the infant is younger of two weeks of age or suffers of G-6-P dehydrogenase deficiency to avoid likelihood of hemolysis. Be aware of false negative results that may be obtained from febrile infants with bacterial cultures when the mother is on antibiotics. Also, the possibility of developing diarrhea due to bacterial flora imbalance.

Nitrofurantoin while Breastfeeding

Safe

CAS Number: 67-20-9

Excretion into breast milk is clinically non-significant with no side-effects observed among breastfed infants from treated mothers except rare cases of diarrhea. Do not use while the infant is younger of two weeks of age or suffers of G-6-P dehydrogenase deficiency to avoid likelihood of hemolysis. Be aware of false negative results that may be obtained from febrile infants with bacterial cultures when the mother is on antibiotics. Also, the possibility of developing diarrhea due to bacterial flora imbalance.


Nitrofurantoin Monohydrate Macrocrystalline | Nitrofurantoin Monohydrate Capsule Breastfeeding Analsys - 2


Nitrofurantoin while Breastfeeding

CAS Number: 67-20-9

Administration of nitrofurantoin directly to infants under 1 month of age and in those with glucose-6-phosphate dehydrogenase (G6PD) deficiency is contraindicated because of potential hemolysis in these infants. However, the time of greatest risk for hemolysis in fullterm newborns without G6PD deficiency might be as short as 8 days after birth.[1] Nitrofurantoin doses in milk are low and it can be used while breastfeeding older infants, but alternate drugs are preferred in mothers of infants under 8 days of age, or infants with G6PD deficiency of any age. Observe infants for possible diarrhea.

Nitrofurantoin while Breastfeeding

CAS Number: 67-20-9

Administration of nitrofurantoin directly to infants under 1 month of age and in those with glucose-6-phosphate dehydrogenase (G6PD) deficiency is contraindicated because of potential hemolysis in these infants. However, the time of greatest risk for hemolysis in fullterm newborns without G6PD deficiency might be as short as 8 days after birth.[1] Nitrofurantoin doses in milk are low and it can be used while breastfeeding older infants, but alternate drugs are preferred in mothers of infants under 8 days of age, or infants with G6PD deficiency of any age. Observe infants for possible diarrhea.



What if I already have used Nitrofurantoin Monohydrate Macrocrystalline | Nitrofurantoin Monohydrate Capsule?

As usage of Nitrofurantoin Monohydrate Macrocrystalline | Nitrofurantoin Monohydrate Capsule is mostly safe while breastfeeding hence there should not be any concern. In case of any change in behavior or health of your baby you should inform your health care provider about usage of Nitrofurantoin Monohydrate Macrocrystalline | Nitrofurantoin Monohydrate Capsule else no further action is required.


My doctor has prescribed me Nitrofurantoin Monohydrate Macrocrystalline | Nitrofurantoin Monohydrate Capsule, what should I do?

Definitely, Nitrofurantoin Monohydrate Macrocrystalline | Nitrofurantoin Monohydrate Capsule is safe in lactation for baby. No wonder your doctor has recommended it.


If I am using Nitrofurantoin Monohydrate Macrocrystalline | Nitrofurantoin Monohydrate Capsule, will my baby need extra monitoring?

No extra baby monitoring required while mother is using Nitrofurantoin Monohydrate Macrocrystalline | Nitrofurantoin Monohydrate Capsule


Who can I talk to if I have questions about usage of Nitrofurantoin Monohydrate Macrocrystalline | Nitrofurantoin Monohydrate Capsule in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week